United States · FDA National Drug Code directory
Dapsone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16714-975_3980db5f-3ff2-2443-e063-6394a90ab484
- Product NDC
- 16714-975
- Form
- GEL
- Composition / generic term
- Dapsone
- Labeler
- NORTHSTAR RX LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20231006
- Source listing expiry
- 20261231
Source-listed ingredients
- DAPSONE — 75 mg/g
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, PUMP in 1 CARTON (16714-975-01) / 60 g in 1 BOTTLE, PUMP · 16714-975-01
- 1 BOTTLE, PUMP in 1 CARTON (16714-975-02) / 90 g in 1 BOTTLE, PUMP · 16714-975-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →